Journal
JOURNAL OF PROTEOME RESEARCH
Volume 5, Issue 1, Pages 177-182Publisher
AMER CHEMICAL SOC
DOI: 10.1021/pr050170g
Keywords
proteomics; myocardial ischemia; isolated organ perfusion; biomarker
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01-HL/AG61483] Funding Source: Medline
Ask authors/readers for more resources
The discovery of novel serological biomarkers is critical for improving disease diagnosis and monitoring treatment response. Proteomic analysis of model systems, such as isolated cells in culture and patient plasma and serum, represents the current state-of-the-art. Here, we coupled proteomics with isolated organ perfusion, which allows a disease state to be studied in a physiologic, yet controlled, environment. Potential markers specific to the disease or to changes in the surrounding tissue may be discovered. The effectiveness of this model was evaluated using proteomic analysis of effluent fractions collected from isolated beating rat hearts during reperfusion after brief episodes of ischemia. The detection of clinical markers for myocardial ischemia in this effluent was robust and analytically straightforward, validating the potential of isolated organ perfusion in diagnostic protein discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available